News & Resources

Client Ramius Prepares for Cypress Bioscience Showdown

October 1, 2010

Westlaw Business highlighted Olshan’s client Ramius LLC announcing that Cypress Bioscience, Inc. has rejected Ramius’ sweetened $4.25 offer and adopted a poison pill designed to make Ramius’ hostile bid more difficult to consummate.

Steve Wolosky, Andrew M. Freedman, Jason W. Soncini and Aneliya S. Crawford comprise the Olshan team representing Ramius.